SEC Form 4 · accession 0000899243-17-013888
Coherus Oncology, Inc. · CHRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mats Wahlstrom
Director
Period of report
May 17, 2017
Accepted (ET)
May 19, 2017 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001512762
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par valueF2 | Feb 22, 2017 | J | 200,000 | $0.00 | D | 378,528 | I | See Footnote |
| Common Stock, $0.0001 par valueF3 | Feb 22, 2017 | J | 109,957 | $0.00 | A | 109,957 | I | See Footnote |
| Common Stock, $0.0001 par valueF2 | May 9, 2017 | J | 200,000 | $0.00 | D | 178,528 | I | See Footnote |
| Common Stock, $0.0001 par valueF3 | May 9, 2017 | J | 109,957 | $0.00 | A | 219,914 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F5 | $23.80 | May 17, 2017 | A | 20,000 | A | — | May 17, 2027 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1KMG Capital Partners, LLC distributed an aggregate of 200,000 shares of common stock of the issuer to its limited and general partners for no consideration on February 22, 2017. Reflects pro rata allocation of such shares distributed to Leonard Capital, LLC.
- F2The shares are held by KMG Capital Partners, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by KMG Capital Partners, LLC except to the extent of his pecuniary interest therein.
- F3The shares are held by Leonard Capital, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by Leonard Capital, LLC except to the extent of his pecuniary interest therein.
- F4KMG Capital Partners, LLC distributed an aggregate of 200,000 shares of common stock of the issuer to its limited and general partners for no consideration on April 27, 2017. Reflects pro rata allocation of such shares distributed to Leonard Capital, LLC.
- F5The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from May 17, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.